TAMING THE FLAMES: INFLAMMATION IN CARDIOMETABOLIC DISEASE
World-renowned experts will present evidence and advances in the prevention and treatment of cardiometabolic disease with a special focus on inflammation.
The 2023 Spring conference from CMHC will focus on practical approaches to identify and address inflammation as well as how to optimize guideline-directed care for patients with cardiometabolic diseases and risk factors.
Low-grade and chronic systemic inflammation is associated with the development of cardiometabolic diseases, including myocardial infarction, stroke, diabetes, heart failure and more. This two-day conference will feature extensive expert panel discussions and opportunities to interact with colleagues and faculty, so clinicians can walk away with practical advice to apply directly to patient care.
of your peers, industry KOLs, and exclusive sponsors for an unforgettable event.
Learn the most cutting-edge
practices, information, from the
world’s most renowned experts in medical and aesthetic dermatology.
Expand your skills to improve your practice with actionable insights you can use
immediately upon returning home.
TOPICS AND EXPERTS WILL REPRESENT IMPROVING CARDIOMETABOLIC HEALTH IN:
Lifestyle, Diet, Physical Activity, Obesity and Inflammation
Physical Activity and Impact on Chronic Inflammation and Cardiometabolic Health: Exploring the Links & Evidence
Transition of NAFLD to NASH: Inflammation is the Culprit
SPEAKER NAME and Credentials
The Impact of Inflammation in Heart Failure: Prevention, Testing, and Treatment
Ileana Piña, MD, MPH
Hypertension & Lipids
Lipoproteins and Inflammation – Focus on LDL, Lp(a) and TG Rich Lipoproteins and New Therapies in Development
Christie M. Ballantyne, Md
Type 2 Diabetes and Kidney Disease
Prevention, Screening and Treatment of Chronic Kidney Disease
Rajiv Agarwal, MD
DON’T MISS THESE TOPICS AND MORE!
Immerse yourself in world-class education and then immerse yourself in relaxation in sunny Orlando, Florida!
Bring on the sun! Hit the links, lounge by the pool, or find your favorite way to relax with the vacation-worthy Gaylord Palms Resort & Convention Center.
2023 CMHC Spring Registration
Here are some common questions we’ll answer NOW, the rest you can ask the experts this May 19-20, 2023, in Orlando!
A: Low-grade systemic inflammation precedes the onset of cardiovascular events by many years, and inflammation is a consistent predictor of cardiovascular risk.
A: A large body of clinical data shows that reducing inflammation has cardiometabolic benefits, and reducing inflammation remains an active area of research that also has important clinical implications, including in the prevention and management of obesity, dyslipidemia, heart failure, chronic kidney disease, hypertension, and type 2 diabetes.
A: An excess of macronutrients in the adipose tissues stimulates inflammatory mediators such as tumor necrosis factor α and interleukin 6; it also reduces the production of adiponectin, promoting inflammation and oxidative stress.
A: Inflammation is a primary mechanism in developed cardiometabolic diseases including coagulation, atherosclerosis, metabolic syndrome, insulin resistance and type 2 diabetes. It is also associated with the development of diseases such as psoriasis, depression, cancer, and renal diseases, conditions that often occur comorbidly in people with cardiometabolic conditions.
A: The activation of nuclear factor kappa B (NF-κB) links pathogenic and cellular danger signals, organizing cellular resistance to perceived threats and triggering inflammation.